000 | 01459 a2200433 4500 | ||
---|---|---|---|
005 | 20250514023606.0 | ||
264 | 0 | _c20020716 | |
008 | 200207s 0 0 eng d | ||
022 | _a0315-162X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCibere, Jolanda | |
245 | 0 | 0 |
_aRheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy. _h[electronic resource] |
260 |
_bThe Journal of rheumatology _cFeb 2002 |
||
300 |
_a339-46 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
650 | 0 | 4 |
_aAnti-Ulcer Agents _xtherapeutic use |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGuideline Adherence |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMisoprostol _xtherapeutic use |
650 | 0 | 4 |
_aPeptic Ulcer _xchemically induced |
650 | 0 | 4 | _aProfessional Practice |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aReminder Systems |
650 | 0 | 4 |
_aRheumatology _xmethods |
650 | 0 | 4 | _aRisk Assessment |
700 | 1 | _aSibley, John T | |
700 | 1 | _aHaga, May | |
773 | 0 |
_tThe Journal of rheumatology _gvol. 29 _gno. 2 _gp. 339-46 |
|
999 |
_c11747833 _d11747833 |